search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
IN PARTNERSHIP


consider epanding yor mareting strategies outside traditional online marketing technies. or eample, people in lowincome


socioeconomic demographics may not have access to the internet or may not have fied hosing. se creative ways, sch as inperson advocates or mail, to reach more participants.


3. Improve Trial Access any participants find trials throgh their specialist doctors after diagnosis. owever, specialists are less likely to see minorities and lowincome patients. or eample, ispanic nerologic patients


were  less liely to see a nerologist than white patients.1 To connect with more patients, epand yor


trial access to doctors and care providers in lowincome areas who may not otherwise learn abot the trial.


4. Adjust Trial Eligibility Criteria To improve the chances of meeting yor diversity goals, the A recommends yo reevalate yor trial eligibility criteria. etting specific insrance, health, or demographic constraints on eligibility can alienate target demographics. inancial assistance and broader criteria, sch as more accepted insrance, can significantly improve yor I participation.


5. Build Trust ffective clinical trials will be patientfocsed. ilding relationships bilds trst, which is especially crucial for minorities. inorities have a rightfl distrst of clinical trials de to past mistreatment and abse. They are now less willing to be participants in trials, even with advanced safety protocols. Address these concerns and establish trst throgh transparency. elp trial participants nderstand what researchers epect of them, what rights they have, and measres yo tae to protect their health and safety. The A also recommends incorporating


operational measres to collect evidence of the trials safety to encorage ftre participation. artnering with instittional review boards or independent ethics committees provides an etra layer of trst. The committees access and


“Many participants nd trials troug teir secialist doctors ater diagnosis. owever secialists are less likely to see minorities and low-income atients.


review safety and trial information to ensure patients are safe and included. Large corporations lie fier have this step in their DEI process.


6. Train Trial Staff Train everyone involved in the trial in diversity, eity, and inclsion, inclding recriters, staff, and researchers so it becomes part of yor culture. Training helps staff recognie potential barriers and offer etra spport as needed. It also teaches critical thining so the team can provide personalied soltions for each patient, depending on their nie sitation. or eample, I training teaches staff correct terminology when addressing people with different bacgronds, religions, disabilities, cltres, and seal orientations.


7. Support Participation Is there anything eeping a patient from participating? Signing up a diverse group for the trial is jst the first step. ow, yo mst spport their contined participation throgh equity and inclusion strategies. Those in lowincome areas might not have


transportation. aybe they cant get time off from wor or childcare. ind ways to remove those barriers, lie offering transportation reimbrsement or a babysitter stipend. o may also choose a location near pblic transportation to help lowincome patients attend the trial. etting p near areas with


Outsourcing In Clinical Trials | 57


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72